United States· US:74157-006_395847bf-ef5e-ef2a-e063-6294a90acf3a
Amcinonide
A amcinonide product containing amcinonide, registered in United States by INA PHARMACEUTICS INC.. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Amcinonide is registered in 4 of 19 countries.
Countries holding a registration under ATC D07AC11 (amcinonide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Amcinonide · ATC D07AC11
4 / 19 countries
- Belgiumprice
- Canada
- Japan
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AMCINONIDE
- Manufacturer
- INA PHARMACEUTICS INC.
- Country
- United States (US)
- ATC code
- D07AC11
- ATC class
- Amcinonide
- Defined daily dose
- 1.5 mg, T
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1174157006601 TUBE in 1 CARTON (74157-006-60) / 60 g in 1 TUBE
- ndc1174157-006-60
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for amcinonide.
Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amcinonide · interactions on record
55 records
Same medicine, other countries
Amcinonide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Belgium · Amicla
- Luxembourg · Amicla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3c8a07c8-f173-492f-8820-dd0d2ebe099d GET /v1/drugs/3c8a07c8-f173-492f-8820-dd0d2ebe099d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1",
"substance": "AMCINONIDE",
"productndc": "74157-006",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/g",
"application_number": "ANDA076229",
"marketing_category": "ANDA"
}See everything about amcinonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.